Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus-Reference-Cited by-同舟云学术

Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus

Published:2022-03 Issue:2 Volume:1 Page:100033
ISSN:2772-9303
Container-title:Journal of the Society for Cardiovascular Angiography & Interventions
language:en
Short-container-title:Journal of the Society for Cardiovascular Angiography & Interventions

Author:

Thomas Alexander^ORCID,Kereiakes Dean J.^ORCID,Baumbach Andreas^ORCID,Windecker Stephan,Pietras Cody^ORCID,Dressler Ovidiu^ORCID,Issever M. Ozgu,Curtis Michael^ORCID,Bertolet Barry^ORCID,Zidar James P.,Smits Pieter C.^ORCID,Jiménez Díaz Victor Alfonso^ORCID,McLaurin Brent,Cequier Ángel,Takahashi Akihiko^ORCID,Cannon Louis A.,Amoroso Giovanni^ORCID,Kakuta Tsunekazu,Saito Shigeru,Leon Martin B.,Lansky Alexandra J.^ORCID

Publisher

Elsevier BV

Reference38 articles.

1. Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI;Chandrasekhar;Catheter Cardiovasc Interv,2020

2. Impact of insulin-treated and noninsulin-treated diabetes mellitus in all-comer patients undergoing percutaneous coronary interventions with polymer-free biolimus-eluting stent (from the RUDI-FREE Registry);Pepe;Am J Cardiol,2019

3. Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial;Konigstein;JACC Cardiovasc Interv,2018

4. Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials;Kedhi;J Am Coll Cardiol,2014

5. Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity: patient-level pooled analysis of 6081 patients;Koskinas;Circ Cardiovasc Interv,2016